BELLEVUE, WA, Feb. 5 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY),
a biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced the launch
of its new corporate website at www.oncothyreon.com.
"We are excited about our new corporate identity and pleased to launch
this updated website, which provides additional information about our product
pipeline and new services for the investment community," said Robert L.
Kirkman, M.D., President and CEO of Oncothyreon.
Those wishing to receive direct notification of Oncothyreon's news
releases, webcasts, events and other information may register online at the
Oncothyreon website by visiting the "News & Events" page under the "Email
Alerts" tab. Please contact Oncothyreon's investor relations department at
firstname.lastname@example.org with any questions about the new site.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
For further information:
For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, email@example.com